Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 4 min 18 sec ago

NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan

Wed, 03/09/2016 - 14:49
Largest and Fastest Growing International Market Readies for Introduction of iGA(TM) Platform to Address Spinal Alignment and Drive Improved Long-Term Patient Outcomes SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a lea...
Devices, Orthopaedic, Neurosurgery, Regulatory
NuVasive, Posterior Fixation, Integrated Global Alignment

Karolinska Development's Portfolio Company Aprea Raises SEK 437 Million

Wed, 03/09/2016 - 14:45
STOCKHOLM, March 9, 2016 -- (Healthcare Sales & Marketing Network) -- Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Aprea AB has successfully raised SEK 437 million ($51 million) in a Series B financing roun...
Biopharmaceuticals, Oncology, Venture Capital
Aprea AB, Karolinska Development, p53

Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel

Tue, 03/08/2016 - 15:23
Strengthens Emphasis on Intellectual Property VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 08, 2016 -- (Healthcare Sales & Marketing Network) -- Arbutus Biopharma Corporation (ABUS), an industry-leading therapeutic solutions company focused on...
Biopharmaceuticals, Personnel
Arbutus Biopharma, hepatitis B virus

Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development

Tue, 03/08/2016 - 15:20
Dr. Wong to Bring Over 15 Years of Experience in Pharmaceutical Business Development to the Company BROOMFIELD, Colo., March 8, 2016 -- (Healthcare Sales & Marketing Network) -- Accera, Inc., a clinical-stage biotechnology company focused on product de...
Biopharmaceuticals, Neurology, Personnel
Accera, Axona , Alzheimer's disease

ImmunoMet Therapeutics Raises $5.2 million in a Series A Financing

Tue, 03/08/2016 - 15:14
Funding to Advance Oncology Development Programs Focused on Cancer Metabolism and Immuno-Oncology Jae Joon Kim Appointed to Board of Directors HOUSTON and DAEJEON, South Korea, March 8, 2016 -- (Healthcare Sales & Marketing Network) -- ImmunoMet The...
Biopharmaceuticals, Oncology, Personnel, Venture Capital
ImmunoMet Therapeutics, glioblastoma

Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls

Tue, 03/08/2016 - 15:11
PHILADELPHIA, PA--(Healthcare Sales & Marketing Network) - Medgenics, Inc. (NYSE MKT: MDGN) today announced the appointment of Rick Couch, Ph.D., as Vice President of Chemistry, Manufacturing and Controls (CMC). In this role, Dr. Couch will be a key member...
Biopharmaceuticals, Personnel
Medgenics, TARGT, genomic medicine

Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health

Mon, 03/07/2016 - 16:02
Amarantus Diagnostics and Theranostics Health operations to consolidate into Avant Diagnostics (AVDX) Theranostics Health customer list includes 7 of the top 10 pharmaceutical companies with estimated pharma services revenue of over $1.5 million in 2015...
Diagnostics, Mergers & Acquisitions
Amarantus Diagnostics, Avant Diagnostics, Theranostics Health

Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer

Mon, 03/07/2016 - 15:54
HAYWARD, Calif., March 07, 2016 -- (Healthcare Sales & Marketing Network) -- Anthera Pharmaceuticals, Inc. (ANTH) today announced the appointment of James Pennington, M.D. as interim Chief Medical Officer following the Company’s acceptance of Colin Hislop’...
Biopharmaceuticals, Personnel
Anthera Pharmaceuticals

Merus Completes Acquisition of Surgestone(R), Provames(R), Tredemine(R) and Speciafoldine(R) Rights from Sanofi

Mon, 03/07/2016 - 15:50
TORONTO, March 7, 2016 -- (Healthcare Sales & Marketing Network) - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] announced today that it has completed the previously announced acquisition of rights ...
Biopharmaceuticals, Acquisitions
Merus Labs, Sanofi, Surgestone, Provames, Tredemine, Speciafoldine

Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases

Mon, 03/07/2016 - 13:28
Now Allows Total of 36 Patients for Skin Regeneration Treatment With ReCell(R) NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company speciali...
Regenerative Medicine, Wound Care, Dermatology, FDA
Avita Medical, ReCell, Regenerative Epithelial Suspension

Astellas Announces Leadership Changes

Fri, 03/04/2016 - 16:04
NORTHBROOK, Ill., March 4, 2016 -- (Healthcare Sales & Marketing Network) -- Astellas today announced various leadership changes that will take effect April 1, 2016. Martin Golden has been appointed to senior vice president and head of Marketing Strate...
Biopharmaceuticals, Personnel
Astellas

Acumed Releases Slide-Loc(TM) Anatomic Radial Head System, Featuring Unique Side-Loading Design

Fri, 03/04/2016 - 14:50
PORTLAND, Ore., March 4, 2016 -- (Healthcare Sales & Marketing Network) -- Acumed is pleased to announce the release of the Acumed Slide-Loc™ Anatomic Radial Head System. This latest addition to our anatomic radial head solutions offers further refinement...
Devices, Orthopaedic, Product Launch
Acumed, Slide-Loc, Anatomic Radial Head System, elbow fracture

Stryker Receives FDA Clearance for Tritanium(R) PL Posterior Lumbar Cage

Fri, 03/04/2016 - 14:40
Advanced 3D Additive Manufacturing Technology Used to Create Proprietary Tritanium Material, for Stryker’s Spine Division, Designed for Bone In-Growth and Biological Fixation ALLENDALE, N.J.--(Healthcare Sales & Marketing Network)--Stryker’s Spine divis...
Devices, Orthopaedic, Neurosurgery, FDA
Stryker, Tritanium PL, Posterior Lumbar Cage, intervertebral body

Bovie Medical Hires Director of Marketing and Two New Region Managers

Fri, 03/04/2016 - 14:34
CLEARWATER, Fla.--(Healthcare Sales & Marketing Network)--Bovie Medical (BVX), a maker of medical devices and supplies, and the developer of J-Plasma®, a patented new surgical product, today announced the hire of a Director of Marketing and two new Reg...
Devices, Surgery, Personnel
Bovie Medical, J-Plasma

Cipher Pharmaceuticals Appoints Ralph Bohrer President and General Manager of U.S. Business

Fri, 03/04/2016 - 14:25
MISSISSAUGA, ON , March 4, 2016 (Healthcare Sales & Marketing Network) - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Ralph Bohrer has joined the Company in the position of Presiden...
Biopharmaceuticals, Dermatology, Personnel
Cipher Pharmaceuticals

3SBio Inc. Announces Expansion of its Leadership Team

Fri, 03/04/2016 - 14:18
Kevin Xiao appointed as chief operating officer SHENYANG, China, March 4, 2016 -- (Healthcare Sales & Marketing Network) -- 3SBio Inc. (Hong Kong: 1530) ("3SBio" and together with its subsidiaries the "3SBio Group") is pleased to a...
Biopharmaceuticals, Personnel
3SBio

Debiopharm International SA Has Won Its Patent Infringement Suit for Elplat(R) Against Nippon Kayaku Co., Ltd.

Fri, 03/04/2016 - 14:11
LAUSANNE, Switzerland, March 4, 2016 -- (Healthcare Sales & Marketing Network) -- Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company today announces that the Tokyo District Court granted Deb...
Biopharmaceuticals, Generics, Oncology, Litigation
Debiopharm Group, Elplat, Oxaliplatin, Nippon Kayaku Co

ReNovo Biotech Partners With Nexus CMF to Distribute Allograft Products

Thu, 03/03/2016 - 20:55
Amniotic Derived Tissues Promise New Treatment Options for CMF Surgeons SALT LAKE CITY, UT--(Healthcare Sales & Marketing Network) - ReNovo Biotech, Inc. (ReNovo), a cellular, tissue and regenerative medicine company, today announced an exclusive partne...
Devices, Regenerative Medicine, Surgery, Distribution
ReNovo Biotech, Nexus CMF, craniomaxillofacial, allograft

Kris Peterson to Join Paratek Board of Directors

Thu, 03/03/2016 - 20:50
BOSTON, March 03, 2016 -- (Healthcare Sales & Marketing Network) -- Paratek Pharmaceuticals, Inc. (PRTK) today announced that Kris Peterson has been elected to the company’s board of directors. Ms. Peterson has more than 30 years of experience in the pharm...
Biopharmaceuticals, Personnel
Paratek Pharmaceuticals, tetracycline

Huya Bioscience International Expands Senior Management Team

Thu, 03/03/2016 - 20:46
Appoints Akira Miyazato, MD, Ph.D. as VP, Head of Clinical Research and Development in Japan SAN DIEGO, March 3, 2016 -- (Healthcare Sales & Marketing Network) -- HUYA Bioscience International (HUYA) today announced the appointment of Akira Miyazato, M...
Biopharmaceuticals, Oncology, Personnel
Huya Bioscience, HBI-8000, lymphoma

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong